Cocci Home Page

Download
PDF version

Other articles
in this issue

Natural Tendencies Stepping out of the box 'Coccidiosis is all we do here' COCCI FAQs Technically Speaking COCCI Views COCCI News

COCCI News

Product updates and industry trends

“Adding value” is an expression producers frequently hear in today’s global poultry industry — and for good reason.

The competition is keen, the market is price-sensitive and international trade agreements can be volatile. Progressive poultry companies know they have to continually raise the bar for quality and consistency to win consumer confidence and to build brand and customer loyalty. It is, after all, the only way to separate your poultry products from the many others in the meat case.

It’s not much different on the animal health side of the business. Sure, Schering- Plough Animal Health Corporation is known worldwide as a leading developer of vaccines in the poultry industry — a business we’ve been honing since we shipped our first batch of vaccine in 1921.

But like you, we’re not alone in this business. We have lots of competitors, some more formidable than others. To win your trust and loyalty, we have to keep bringing “added value” to our products.

Providing expertise and top-notch technical support is, of course, one way we try to meet that objective. By working side-by-side with our customers, conducting field trials, presenting new ideas at industry meetings and publishing information in technical bulletins, scientific journals and, of course, our own CocciForum magazine, we’re committed to keeping our customers on the forefront of coccidiosis management.

Perhaps less apparent to our customers is the work we do behind the scenes to ensure vaccine quality and consistency. Let’s face it: Virtually any company with a fermenter and a government license can call itself a vaccine manufacturer. However, it takes an industry leader — with its rigid guidelines for quality assurance and control that often exceed government criteria — to deliver the consistency and performance that you demand from a vaccine.

This is particularly important for coccidiosis vaccines, where plant QA/QC procedures and meticulous biosecurity need to be paramount to avoid introducing new pathogens to vaccines. Maintaining the right balance of Eimeria antigens is also critical to producer performance and safety.

It is for these reasons that I hope you’ll take time to read our Special Report on the intricacies of coccidiosis vaccine production and the steps we’ve taken to bring you “added value.”



Source: CocciForum Issue No.5, Schering-Plough Animal Health.